251 related articles for article (PubMed ID: 29275584)
1. [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].
Xia J; Lü ZD; Zhou PH; Cui SC; Kong B; Liu D; Long SS; Zhang XH; Zhao JJ
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3483-3487. PubMed ID: 29275584
[No Abstract] [Full Text] [Related]
2. Down-regulation of BRMS1 by DNA hypermethylation and its association with metastatic progression in triple-negative breast cancer.
Kong B; Lv ZD; Wang Y; Jin LY; Ding L; Yang ZC
Int J Clin Exp Pathol; 2015; 8(9):11076-83. PubMed ID: 26617826
[TBL] [Abstract][Full Text] [Related]
3. [The study of expression of BRMS1 gene protein and the expression of BRMS1 gene promotor area methylation in supraglottic laryngeal carcinoma and its clinical significance].
Li X; Wu Y; Sun Y; Huang M; Ma D; Xu J; Guo X; Jiang X; Guan C; Li F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(15):701-3. PubMed ID: 23167184
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.
Chimonidou M; Kallergi G; Georgoulias V; Welch DR; Lianidou ES
Mol Cancer Res; 2013 Oct; 11(10):1248-57. PubMed ID: 23744981
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.
Chimonidou M; Strati A; Tzitzira A; Sotiropoulou G; Malamos N; Georgoulias V; Lianidou ES
Clin Chem; 2011 Aug; 57(8):1169-77. PubMed ID: 21700955
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
Metge BJ; Frost AR; King JA; Dyess DL; Welch DR; Samant RS; Shevde LA
Clin Exp Metastasis; 2008; 25(7):753-63. PubMed ID: 18566899
[TBL] [Abstract][Full Text] [Related]
7. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
9.
Lin LZ; Cai MG; Dai YC; Zheng ZB; Jiang FF; Shi LL; Pan Y; Song HB
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28533425
[TBL] [Abstract][Full Text] [Related]
10. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
Zhang S; Lin QD; DI W
Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
[TBL] [Abstract][Full Text] [Related]
11. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer.
Zhang Z; Yamashita H; Toyama T; Yamamoto Y; Kawasoe T; Iwase H
Clin Cancer Res; 2006 Nov; 12(21):6410-4. PubMed ID: 17085653
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis suppressor gene, breast cancer metastasis suppressor 1, may be associated with clinicopathological features of breast cancer.
Lin L; Cai M; Dai Y; Zheng Z; Jiang F; Shi L; Pan Y; Song HB
J Cancer Res Ther; 2018 Jun; 14(Supplement):S368-S374. PubMed ID: 29970691
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
16. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
Guo GC; Wang JX; Han ML; Zhang LP; Li L
Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.
Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM
Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034
[TBL] [Abstract][Full Text] [Related]
19. Histone demethylase JARID1C promotes breast cancer metastasis cells via down regulating BRMS1 expression.
Wang Q; Wei J; Su P; Gao P
Biochem Biophys Res Commun; 2015 Aug; 464(2):659-66. PubMed ID: 26182878
[TBL] [Abstract][Full Text] [Related]
20. Expression of the breast cancer metastasis suppressor gene, BRMS1, in human breast carcinoma: lack of correlation with metastasis to axillary lymph nodes.
Kelly LM; Buggy Y; Hill A; O'Donovan N; Duggan C; McDermott EW; O'Higgins NJ; Young L; Duffy MJ
Tumour Biol; 2005; 26(4):213-6. PubMed ID: 16006775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
